Nomura Asset Management CO LTD Amarin Corp Plcuk Transaction History

Nomura Asset Management CO LTD

9 transactions

Quarter	Operation	Price Per share	shares change
Q2 2021 Aug 06, 2021	SELL	$4.26 - $6.5 $0 - $0	0 Closed
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $0 - $0	0 New

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.